U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 25

1.
The role of cytochrome P450 gene rs1126742 polymorphism and risk of hypertension: a systematic review and meta-analysis
Ziyin Huang, Yufeng Jiang, Yafeng Zhou
Biosci Rep. 2020 May 29; 40(5): BSR20192513. Published online 2020 May 22. doi: 10.1042/BSR20192513
PMCID:
PMC7244898
ArticlePDF–807K
2.
CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation
Huifang Gao, Yaru Cao, Hongguang Xia, Xiangyu Zhu, Yong Jin
Int J Mol Med. 2020 Apr; 45(4): 1121–1129. Published online 2020 Jan 28. doi: 10.3892/ijmm.2020.4479
PMCID:
PMC7053872
ArticlePDF–755K
3.
Heme–thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition
Matthew E. Albertolle, Donghak Kim, Leslie D. Nagy, Chul-Ho Yun, Ambra Pozzi, Üzen Savas, Eric F. Johnson, F. Peter Guengerich
J Biol Chem. 2017 Jul 7; 292(27): 11230–11242. Published online 2017 May 22. doi: 10.1074/jbc.M117.792200
PMCID:
PMC5500791
ArticlePDF–1.2M
4.
20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR
Üzen Savas, Shouzou Wei, Mei-Hui Hsu, John R. Falck, F. Peter Guengerich, Jorge H. Capdevila, Eric F. Johnson
J Biol Chem. 2016 Aug 5; 291(32): 16904–16919. Published online 2016 Jun 13. doi: 10.1074/jbc.M116.732297
PMCID:
PMC4974402
ArticlePDF–4.4M
5.
Kinetic Analysis of Lauric Acid Hydroxylation by Human Cytochrome P450 4A11
Donghak Kim, Gun-Su Cha, Leslie D. Nagy, Chul-Ho Yun, F. Peter Guengerich
Biochemistry. 2014 Oct 7; 53(39): 6161–6172. Published online 2014 Sep 9. doi: 10.1021/bi500710e
PMCID:
PMC4188250
ArticlePDF–1.4M
6.
GENETIC VARIATION IN CYP4A11 AND BLOOD PRESSURE RESPONSE TO MINERALOCORTICOID RECEPTOR ANTAGONISM OR ENAC INHIBITION: AN EXPLORATORY PILOT STUDY IN AFRICAN AMERICANS
Cheryl L. Laffer, Fernando Elijovich, George J. Eckert, Wanzhu Tu, J. Howard Pratt, Nancy J. Brown
J Am Soc Hypertens. Author manuscript; available in PMC 2015 Jul 1.
Published in final edited form as: J Am Soc Hypertens. 2014 Jul; 8(7): 475–480. Published online 2014 May 9. doi: 10.1016/j.jash.2014.04.011
PMCID:
PMC4115247
ArticlePDF–421K
7.
Association between the CYP4A11 T8590C Variant and Essential Hypertension: New Data from Han Chinese and a Meta-Analysis
Hua-Cheng Yan, Jun-Hua Liu, Jian Li, Bao-Xia He, Liang Yang, Jian Qiu, Liang Li, Da-Peng Ding, Lei Shi, Shu-Jin Zhao
PLoS One. 2013; 8(11): e80072. Published online 2013 Nov 21. doi: 10.1371/journal.pone.0080072
PMCID:
PMC3836999
ArticlePDF–238K
8.
CYP4A11 variant is associated with high density lipoprotein cholesterol in women
Charles C. White, QiPing Feng, L. Adrienne Cupples, James V. Gainer, Elliott P. Dawson, Russell A. Wilke, Nancy J. Brown
Pharmacogenomics J. Author manuscript; available in PMC 2013 Aug 1.
Published in final edited form as: Pharmacogenomics J. 2013 Feb; 13(1): 44–51. Published online 2011 Sep 13. doi: 10.1038/tpj.2011.40
PMCID:
PMC3380161
ArticlePDF–364K
9.
CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow
Jonathan S. Williams, Paul N. Hopkins, Xavier Jeunemaitre, Nancy J. Brown
J Hypertens. Author manuscript; available in PMC 2012 Oct 1.
Published in final edited form as: J Hypertens. 2011 Oct; 29(10): 1913–1918. doi: 10.1097/HJH.0b013e32834aa786
PMCID:
PMC3309034
ArticlePDF–1.2M
10.
Association of a CYP4A11 Variant and Blood Pressure in Black Men
James V. Gainer, Michael S. Lipkowitz, Chang Yu, Michael R. Waterman, Elliott P. Dawson, Jorge H. Capdevila, Nancy J. Brown, and the AASK Study Group
J Am Soc Nephrol. 2008 Aug; 19(8): 1606–1612. doi: 10.1681/ASN.2008010063
PMCID:
PMC2488260
Article
11.
The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension
Cheryl L. Laffer, James V. Gainer, Michael R. Waterman, Jorge H. Capdevila, Michal Laniado-Schwartzman, Alberto Nasjletti, Nancy J. Brown, Fernando Elijovich
Hypertension. Author manuscript; available in PMC 2009 Feb 1.
Published in final edited form as: Hypertension. 2008 Mar; 51(3): 767–772. Published online 2008 Jan 28. doi: 10.1161/HYPERTENSIONAHA.107.102921
PMCID:
PMC2365894
ArticlePDF–355K
12.
A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease
Svetlana Sirotina, Irina Ponomarenko, Alexander Kharchenko, Marina Bykanova, Anna Bocharova, Kseniya Vagaytseva, Vadim Stepanov, Mikhail Churnosov, Maria Solodilova, Alexey Polonikov
Dis Markers. 2018; 2018: 5812802. Published online 2018 Feb 1. doi: 10.1155/2018/5812802
PMCID:
PMC5816861
ArticlePDF–879K
13.
Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level
Duanxiu Liao, Xingyang Yi, Biao Zhang, Qiang Zhou, Jing Lin
Genet Test Mol Biomarkers. 2016 May 1; 20(5): 223–228. doi: 10.1089/gtmb.2015.0205
PMCID:
PMC4876528
ArticlePDF–144K
14.
Cytochrome 4A11 Genetic Polymorphisms Increase Susceptibility to Ischemic Stroke and Associate with Atherothrombotic Events After Stroke in Chinese
Biao Zhang, Xingyang Yi, Chun Wang, Duanxiu Liao, Jing Lin, Lifen Chi
Genet Test Mol Biomarkers. 2015 May 1; 19(5): 235–241. doi: 10.1089/gtmb.2014.0305
PMCID:
PMC4432775
ArticlePDF–142K
15.
Association of Common Variants of CYP4A11 and CYP4F2 with Stroke in the Han Chinese Population
Hu Ding, Guanglin Cui, Lan Zhang, Yujun Xu, Xunna Bao, Yuanchao Tu, Bin Wu, Qi Wang, Rutai Hui, Wei Wang, Ryan T. Dackor, Grace E. Kissling, Darryl C. Zeldin, Dao Wen Wang
Pharmacogenet Genomics. Author manuscript; available in PMC 2014 Feb 24.
Published in final edited form as: Pharmacogenet Genomics. 2010 Mar; 20(3): 187–194. doi: 10.1097/FPC.0b013e328336eefe
PMCID:
PMC3932492
ArticlePDF–102K
16.
Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke
Xingyang Yi, Lang Wu, Duanxiu Liao, Chun Wang, Biao Zhang
J Atheroscler Thromb. 2016 Nov 1; 23(11): 1286–1293. doi: 10.5551/jat.35279
PMCID:
PMC5065934
ArticlePDF–115K
17.
Opposing Roles of Peroxisome Proliferator-activated Receptor α and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model
Üzen Savas, Daniel E. W. Machemer, Mei-Hui Hsu, Pryce Gaynor, Jerome M. Lasker, Robert H. Tukey, Eric F. Johnson
J Biol Chem. 2009 Jun 12; 284(24): 16541–16552. Published online 2009 Apr 14. doi: 10.1074/jbc.M902074200
PMCID:
PMC2713544
ArticlePDF–872K
18.
Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile
Zhi Chen, Hao Wu, Guohua Wang, Ye Feng
BMC Nephrol. 2016; 17: 149. Published online 2016 Oct 18. doi: 10.1186/s12882-016-0366-8
PMCID:
PMC5069870
ArticlePDF–1.7M
19.
Genetic Associations with Hypertension: Meta-Analyses of Six Candidate Genetic Variants
Cheng Zhang, Lingyan Wang, Qi Liao, Lina Zhang, Leiting Xu, Cheng Chen, Huadan Ye, Xuting Xu, Meng Ye, Shiwei Duan
Genet Test Mol Biomarkers. 2013 Oct; 17(10): 736–742. doi: 10.1089/gtmb.2013.0080
PMCID:
PMC3780324
ArticlePDF–400K
20.
Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs.
D R Bell, N J Plant, C G Rider, L Na, S Brown, I Ateitalla, S K Acharya, M H Davies, E Elias, N A Jenkins, et al.
Biochem J. 1993 Aug 15; 294(Pt 1): 173–180. doi: 10.1042/bj2940173
PMCID:
PMC1134581
SummaryPage BrowsePDF–1.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center